|
[1]
|
Michelucci, A., Cordes, T., Ghelfi, J., et al. (2013) Immune-Responsive Gene 1 Protein Links Metabolism to Immunity by Catalyzing Itaconic Acid Production. Proceedings of the National Academy of Sciences of the United States of America, 110, 7820-7825. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mills, E.L., Ryan, D.G., Prag, H.A., et al. (2018) Itaconate Is an Anti-Inflammatory Metabolite That Activates Nrf2 via Alkylation of KEAP1. Nature, 556, 113-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chen, Y.-J., Li, G.-N., Li, X.-J., et al. (2023) Targeting IRG1 Reverses the Immunosuppressive Function of Tumor-Associated Macrophages and Enhances Cancer Immunotherapy. Science Advances, 9, eadg0654. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Aso, K., Kono, M., Kanda, M., et al. (2023) Itaconate Ameliorates Autoimmunity by Modulating T Cell Imbalance via Metabolic and Epigenetic Reprogramming. Nature Communications, 14, Article No. 984. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Wu, R., Chen, F., Wang, N., et al. (2020) Acod1 in Immunome-tabolism and Disease. Cellular & Molecular Immunology, 17, 822-833. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Radi, Z.A. (2019) Kidney Pathophysiology, Toxicology, and Drug-Induced Injury in Drug Development. International Journal of Toxicology, 38, 215-227. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Pereira, M., Chen, T.D., Buang, N., et al. (2019) Acute Iron Dep-rivation Reprograms Human Macrophage Metabolism and Reduces Inflammation in Vivo. Cell Reports, 28, 498-511.E5. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Zhu, D., Zhao, Y., Luo, Y., et al. (2021) Irg1-Itaconate Axis Protects Against Acute Kidney Injury via Activation of Nrf2. American Journal of Translational Research, 13, 1155-1169.
|
|
[9]
|
McFadden, B.A. and Purohit, S. (1977) Itaconate, an Isocitrate Lyase-Directed Inhibitor in Pseudo-monas indigofera. Journal of Bacteriology, 131, 136-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Berg, I.A., Filatova, L.V. and Ivanovsky, R.N. (2002) Inhibition of Acetate and Propionate Assimilation by Itaconate via Pro-pionyl-Coa Carboxylase in Isocitrate Lyase-Negative Purple Bacterium Rhodospirillum rubrum. FEMS Microbiology Letters, 216, 49-54. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Zhang, Z., Chen, C., Yang, F., et al. (2022) Itaconate Is a Lysosomal Inducer That Promotes Antibacterial Innate Immunity. Molecular Cell, 82, 2844-2857.E10. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
O’Neill, L.A.J. and Artyomov, M.N. (2019) It-aconate: The Poster Child of Metabolic Reprogramming in Macrophage Function. Nature Reviews Immunology, 19, 273-281. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Strelko, C.L., Lu, W., Dufort, F.J., et al. (2011) Itaconic Acid Is A Mammalian Metabolite Induced during Macrophage Activation. Journal of the American Chemical Society, 133, 16386-16389. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Bambouskova, M., Potuckova, L., Paulenda, T., et al. (2021) Itaconate Confers Tolerance to Late NLRP3 Inflammasome Activation. Cell Reports, 34, Article 108756. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lampropoulou, V., Sergushichev, A., Bambouskova, M., et al. (2016) Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. Cell Metabolism, 24, 158-166. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bambouskova, M., Gorvel, L., Lampropoulou, V., et al. (2018) Electrophilic Properties of Itaconate and Derivatives Regulate the IκBζ-ATF3 Inflammatory Axis. Nature, 556, 501-504. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Labzin, L.I., Schmidt, S.V., Masters, S.L., et al. (2015) ATF3 Is a Key Regulator of Macrophage IFN Responses. The Journal of Immunology, 195, 4446-4455. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
ElAzzouny, M., Tom, C.T.M.B., Evans, C.R., et al. (2017) Dime-thyl Itaconate Is Not Metabolized into Itaconate Intracellularly. Journal of Biological Chemistry, 292, 4766-4769. [Google Scholar] [CrossRef]
|
|
[19]
|
Huang, S.-S., Guo, D.-Y., Jia, B.-B., et al. (2021) Dimethyl Ita-conate Alleviates the Pyroptosis of Macrophages through Oxidative Stress. BMC Immunology, 22, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhang, S., Jiao, Y., Li, C., et al. (2021) Dimethyl Itaconate Alle-viates the Inflammatory Responses of Macrophages in Sepsis. Inflammation, 44, 549-557. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Li, Y., Chen, X., Zhang, H., et al. (2020) 4-Octyl Itaconate Alle-viates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting Oxidative Stress and Inflammation. Drug Design, Development and Therapy, 14, 5547-5558. [Google Scholar] [CrossRef]
|
|
[22]
|
Li, Y., Li, B., Xiao, X., et al. (2023) Itaconate Inhibits CD103+ TRM Cells and Alleviates Hepatobiliary Injury in Mouse Models of Primary Sclerosing Cholangitis. Hepatology, 79, 25-38. [Google Scholar] [CrossRef]
|
|
[23]
|
Swain, A., Bambouskova, M., Kim, H., et al. (2020) Com-parative Evaluation of Itaconate and Its Derivatives Reveals Divergent Inflammasome and Type I Interferon Regulation in Macrophages. Nature Metabolism, 2, 594-602. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Olagnier, D., Brandtoft, A.M., Gunderstofte, C., et al. (2018) Nrf2 Negatively Regulates Sting Indicating a Link between Antiviral Sensing and Metabolic Reprogramming. Nature Communications, 9, Article No. 3506. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Xu, L., Cai, J., Li, C., et al. (2023) 4-Octyl Itaconate Attenuates LPS-Induced Acute Kidney Injury by Activating Nrf2 and Inhibiting STAT3 Signaling. Molecular Medicine, 29, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kim, T.W., Cheon, C. and Ko, S.G. (2020) SH003 Ac-tivates Autophagic Cell Death by Activating ATF4 and Inhibiting G9a under Hypoxia in Gastric Cancer Cells. Cell Death and Disease, 11, Article No. 717. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Zhou, Y., Xu, W. and Zhu, H. (2019) CXCL8(3-72) K11R/G31P Protects Against Sepsis-Induced Acute Kidney Injury via Nf-κB and JAK2/STAT3 Pathway. Biological Research, 52, Article No. 29. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Sun, S., Wang, J., Wang, J., et al. (2019) Maresin 1 Mitigates Sepsis-Associated Acute Kidney Injury in Mice via Inhibition of the NF-κB/STAT3/MAPK Pathways. Frontiers in Pharmacology, 10, Article 1323. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Hato, T., Zollman, A., Plotkin, Z., et al. (2018) Endotoxin Precondi-tioning Reprograms S1 Tubules and Macrophages to Protect the Kidney. Journal of the American Society of Nephrology, 29, 104-117. [Google Scholar] [CrossRef]
|
|
[30]
|
Xu, J., Liu, L., Gan, L., et al. (2021) Berberine Acts on C/EBPβ/lncRNA Gas5/miR-18a-5p Loop to Decrease the Mitochondrial ROS Generation in HK-2 Cells. Frontiers in Endocrinology (Lausanne), 12, Article 675834. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Rayego-Mateos, S., Marquez-Exposito, L., Rodrigues-Diez, R., et al. (2022) Molecular Mechanisms of Kidney Injury and Repair. International Journal of Molecular Sciences, 23, Article 1542. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Li, X., Mu, G., Song, C., et al. (2018) Role of M2 Macrophages in Sepsis-Induced Acute Kidney Injury. Shock, 50, 233-239. [Google Scholar] [CrossRef]
|
|
[33]
|
Feng, Y., Ren, J., Gui, Y., et al. (2018) Wnt/β-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis. Journal of the American Society of Nephrology, 29, 182-193. [Google Scholar] [CrossRef]
|
|
[34]
|
Klessens, C.Q.F., Zandbergen, M., Wolterbeek, R., et al. (2017) Macrophages in Diabetic Nephropathy in Patients with Type 2 Diabetes. Nephrology Dialysis Transplantation, 32, 1322-1329. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Runtsch, M.C., Angiari, S., Hooftman, A., et al. (2022) Ita-conate and Itaconate Derivatives Target JAK1 to Suppress Alternative Activation of Macrophages. Cell Metabolism, 34, 487-501.E8. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Meng, X.-M., Nikolic-Paterson, D.J. and Lan, H.Y. (2016) TGF-β: The Master Regulator of Fibrosis. Nature Reviews Nephrology, 12, 325-338. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Tian, F., Wang, Z., He, J., et al. (2020) 4-Octyl Itaconate Protects Against Renal Fibrosis via Inhibiting TGF-Beta/ Smad Pathway, Autophagy and Reducing Generation of Reactive Oxy-gen Species. European Journal of Pharmacology, 873, Article 172989. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ke, Q., Shi, C., Lv, Y., et al. (2022) SGLT2 Inhibitor Counter-acts NLRP3 Inflammasome via Tubular Metabolite Itaconate in Fibrosis Kidney. The FASEB Journal, 36, e22078. [Google Scholar] [CrossRef]
|
|
[39]
|
Hooftman, A., Angiari, S., Hester, S., et al. (2020) The Immuno-modulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cell Metabolism, 32, 468-478.E467. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Hoyle, C., Green, J.P., Allan, S.M., et al. (2022) Itaconate and Fumarate Derivatives Inhibit Priming and Activation of the Canonical NLRP3 Inflammasome in Macro-phages. Immunology, 165, 460-480. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Mohan, C. and Putterman, C. (2015) Genetics and Pathogenesis of Systemic Lupus Erythematosus and Lupus Nephritis. Nature Reviews Nephrology, 11, 329-341. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Su, D.-L., Lu, Z.-M., Shen, M.-N., et al. (2012) Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE. Journal of Biomedicine and Biotechnology, 2012, Article ID: 347141. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Suzuki, T. and Yamamoto, M. (2015) Molecular Basis of the Keap1-Nrf2 System. Free Radical Biology and Medicine, 88, 93-100. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Wardyn, J.D., Ponsford, A.H. and Sanderson, C.M. (2015) Dissecting Molecular Cross-Talk between Nrf2 and Nf-κB Response Pathways. Biochemical Society Transac-tions, 43, 621-626. [Google Scholar] [CrossRef]
|
|
[45]
|
Yoh, K., Itoh, K., Enomoto, A., et al. (2001) Nrf2-Deficient Female Mice Develop Lupus-Like Autoimmune Nephritis. Kidney International, 60, 1343-1353. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Tang, C., Wang, X., Xie, Y., et al. (2018) 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients. Cellular Physiology and Biochemistry, 51, 979-990. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Blanco, L.P., Patino-Martinez, E., Nakabo, S., et al. (2022) Modulation of the Itaconate Pathway Attenuates Murine Lupus. Arthritis & Rheumatology, 74, 1971-1983. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Chen, A., Lee, K. and He, J.C. (2022) Treating Crescentic Glomerulonephri-tis by Targeting Macrophages. Kidney International, 102, 1212-1214. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Xie, D., Zhao, H., Xu, X., et al. (2021) Intensity of Macrophage In-filtration in Glomeruli Predicts Response to Immunosuppressive Therapy in Patients with IGA Nephropathy. Journal of the American Society of Nephrology, 32, 3187-3196. [Google Scholar] [CrossRef]
|